Generic Drug Group Defends Pause on Minnesota Pricing Law (1)

The national group representing generic and biosimilar manufacturers is urging a federal appeals court to uphold an injunction on a Minnesota law that aims to limit price hikes on generic drugs, citing recent precedent on laws affecting interstate transactions.

The US District Court for the District of Minnesota “applied binding precedent to hold that the Minnesota law violates the dormant Commerce Clause when it directly regulates prices charged in wholly out-of-state transactions,” the Association for Accessible Medicines wrote in a brief filed April 12 in the US Court of Appeals for the Eighth Circuit.

The filing comes in response to ...